Akebia Therapeutics Inc (NASDAQ:AKBA)

0.397
Delayed Data
As of 4:41pm ET
 +0.0518 / +15.01%
Today’s Change
0.30
Today|||52-Week Range
3.91
-82.43%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 1.25, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +214.86% increase from the last price of 0.40.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Akebia Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$51.0M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.43%
 
 
 
 
 
 
Growthannually 51.47%
 
 
 
 
 
 

Sales

Growthquarterly -17.41%
 
 
 
 
 
 
Growthannually -2.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.